Evaluation of sesamol-induced histopathological, biochemical, haematological and genomic alteration after acute oral toxicity in female C57BL/6 mice

• Published in: Toxicology reports Vol. 3; pp. 880 - 894
• Main Authors: Khan, Shahanshah, Choudhary, Sandeep, Kumar, Arun, Tripathi, Akanchha Mani, Alok, Amit, Adhikari, Jawahar Singh, Rizvi, Moshahid Alam, Chaudhury, Nabo Kumar
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier 01-01-2016
• Subjects: Sesamol; Haematology; Histopathology; Micronucleus assay; Comet assay; Acute toxicity
• ISSN: 2214-7500; 2214-7500
• DOI: 10.1016/j.toxrep.2016.03.005

The objective of this study was to evaluate organ-wise toxicological effects of sesamol and determine the LD
cut-off value and GHS category following acute oral toxicity method OECD 423. An acute oral toxicity study was carried out in female C57BL/6 mice. Observations for physical behaviour and measurements on haematology, biochemistry, histology of vital organs were performed. In addition, genotoxicity assessment using comet and micronuclei assays was also performed. Acute toxicological effects were observed at 2000 mg/kg, while no adverse effects observed at 300 mg/kg. The effects of 2000 mg/kg were manifested as severe histopathological changes in all organs (femur, spleen, gastrointestine, lungs, heart, kidney, liver, stomach and brain) and excessive DNA strands breaks occurred in femoral bone marrow cells and splenocytes. A single dose of sesamol (2000 mg/kg, body weight) caused the death of two mice (out of three) within 2 h. Hence, sesamol is in GHS category 4 (>300-2000) with LD
cut-off value of 500 mg/kg body weight. In contrast, this study is correlated with the obtained GHS category 4 and LD
cut-off value 580 mg/kg body weight by ProTox. In conclusions, the present study has classified sesamol toxicity and assessed organ-wise acute oral toxicity of sesamol in female C57BL/6 mice. Therefore, these findings may be useful for the selection of dosages for further pre-clinical evaluation and potential drug developmental of sesamol.